Are you Dr. Gertz?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 49 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
126 E Lincoln Ave
Rahway, NJ 07065Phone+1 732-594-5410Fax+1 732-594-7310- Is this information wrong?
Summary
- Dr. Barry Gertz, MD is an endocrinologist in Rahway, New Jersey. He is currently licensed to practice medicine in New Jersey, New York, and California.
Education & Training
University of California (San Francisco)Fellowship, Endocrinology, Diabetes, and Metabolism, 1983 - 1985- University of California (San Francisco)Fellowship, Endocrinology, Diabetes, and Metabolism, 1982 - 1983
University of Pennsylvania Health SystemResidency, Internal Medicine, 1979 - 1982
Perelman School of Medicine at the University of PennsylvaniaClass of 1979
Certifications & Licensure
CA State Medical License 1982 - Present
NY State Medical License 1986 - 2024
NJ State Medical License 1988 - 2015
PA State Medical License 1981 - 1990- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- 1 citationsUncontrolled Extensions of Clinical Trials and the Use of External Controls-Scoping Opportunities and Methods.Ching-Yu Wang, Jesse A. Berlin, Barry J. Gertz, Kourtney Davis, Jie Li, Nancy A Dreyer, Wei Zhou, John D. Seeger, Nancy C. Santanello, Almut G. Winterstein> ;Clinical Pharmacology and Therapeutics. 2021 Aug 10
- 21 citationsMethods for external control groups for single arm trials or long-term uncontrolled extensions to randomized clinical trials.John D. Seeger, Kourtney Davis, Michelle R. Iannacone, Wei Zhou, Nancy A Dreyer, Almut G. Winterstein, Nancy C. Santanello, Barry J. Gertz, Jesse A. Berlin> ;Pharmacoepidemiology and Drug Safety. 2020 Oct 4
- 152 Development of Deutetrabenazine as a Potential New Non-Antipsychotic Treatment for Tourette Syndrome in Children and AdolescentsJoseph Jankovic, Barbara J. Coffey, Daniel O. Claassen, David Stamler, Barry J Gertz, Elisabeth A. Garofalo, Maria Wieman, Mark Forrest Gordon, Juha-Matti Savola> ;Cns Spectrums. 2020 Apr 1
- Join now to see all
Press Mentions
Clarus Promotes Dr. Emmett Cunningham to Managing Director, Dr. Barry Gertz to Partner, and Dr. Ari Brettman to PrincipalJanuary 6th, 2017
